Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Short term Debt: 2022

Historic Short term Debt for Orchestra BioMed Holdings (OBIO) over the last 1 years, with Dec 2022 value amounting to $2.1 million.

  • Orchestra BioMed Holdings' Short term Debt was N/A to $9.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $9.6 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2022, which is N/A change from last year.
  • Orchestra BioMed Holdings' Short term Debt amounted to $2.1 million in FY2022.
  • In the past 5 years, Orchestra BioMed Holdings' Short term Debt ranged from a high of $2.1 million in FY2022 and a low of $2.1 million during FY2022.
  • In the last 1 years, Orchestra BioMed Holdings' Short term Debt had a median value of $2.1 million in 2022 and averaged $2.1 million.